Published in Surgery Litigation and Law Weekly, November 24th, 2006
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Acologix.
Report 1: Acologix, Inc. has licensed technology from the University of Maryland, Baltimore, for the potential treatment of interstitial cystitis (IC).
A chronic bladder condition characterized by serious pain and increased frequency of urination, interstitial cystitis affects an estimated 700,000 Americans, of whom approximately 90% are women. To date, there are no satisfactory treatments for this condition.
Acologix' license includes patents related to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly